Copper(II), palladium(II) and platinum(II) chloride complexes with 5-amino-2-tert-butyltetrazole: Synthesis, characterization and cytotoxicity

Complexes CuL₃Cl₂, PdL₂Cl₂ and PtL₂Cl₂, where L is a novel ligand from the series of 2-substituted 5-aminotetrazoles, namely 5-amino-2-tert-butyltetrazole (1), have been synthesized by the reaction of metal(II) chlorides with 1 and characterized by IR spectroscopy, thermal and X-ray analyses. The crystallographic structural analysis of these complexes revealed that 1 acts as a monodentate ligand coordinated to the metal via endocyclic N4 atom. Platinum complex demonstrates promising cytotoxicity against human cervical carcinoma cells with IC₅₀ value average between those of cisplatin and carboplatin.     

Synthesis and structure of highly substituted pyrazole ligands and their complexes with platinum(II) and palladium(II) metal ions

Reaction of 3-methoxycarbonyl-2-methyl- or 3-dimethoxyphosphoryl-2-methyl-substituted 4-oxo-4H-chromones 1 with N-methylhydrazine resulted in the formation of isomeric, highly substituted pyrazoles 4 (major products) and 5 (minor products). Intramolecular transesterification of 4 and 5 under basic conditions led, respectively, to tricyclic derivatives 7 and 8. The structures of pyrazoles 4a (dimethyl 2-methyl-4-oxo-4H-chromen-3-yl-phosphonate) and 4b (methyl 4-oxo-2-methyl-4H-chromene-3-carboxylate) were confirmed by X-ray crystallography. Pyrazoles 4a and 4b were used as ligands (L) in the formation of ML₂Cl₂ complexes with platinum(II) or palladium(II) metal ions (M). Potassium tetrachloroplatinate(II), used as the metal ion reagent, gave both trans-[Pt(4a)₂Cl₂] and cis-[Pt(4a)₂Cl₂], complexes with ligand 4a, and only cis-[Pt(4b)₂Cl₂] isomer with ligand 4b. Palladium complexes were obtained by the reaction of bis(benzonitrile)dichloropalladium(II) with the test ligands. trans-[Pd(4a)₂Cl₂] and trans-[Pd(4b)₂Cl₂] were the exclusive products of these reactions. The structures of all the complexes were confirmed by IR, ¹H NMR and FAB MS spectral analysis, elemental analysis and Kurnakov tests.     

Synthesis,characterization and in vitro cytotoxicity of platinum(II) complexes of selenones [Pt(selenone)2Cl2]

Platinum(II) complexes with various selenones (L) having the general formula [PtL₂Cl₂] were prepared and characterized by elemental analysis and, IR and NMR (¹H, ¹³C, and ⁷⁷Se) spectroscopies. A decrease in the IR frequency of the >C=Se mode and an upfield shift in ¹³C NMR for the >C=Se resonance of selenones are consistent with their selenium coordination to platinum(II). The NMR data show that the complexes are stable in solution and do not undergo equilibration at 297 K. The geometrical structures of the complexes were predicted theoretically (with DFT method) using Gaussian09 program. DFT calculations predicted that the trans configurations were up to 1.7 kcal/mol more stable than the cis forms in gas phase, while in solution form the cis isomers were predicted to be more stable. The UV–vis spectra of the two complexes, 6 and 7 were also recorded at room temperature for 24 h and it was observed that the complexes were stable and did not undergo decomposition. The in vitro antitumor properties of the complexes as well as of cisplatin were evaluated on two human cancer cell lines, HeLa (cervical cancer cells) and MCF7 (breast cancer cells) using MTT assay. The results indicated that the prepared complexes exerted significant inhibition on the selected cancer cells.     

Synthesis,structure, protein binding,and cytotoxicity of zinc(II) complexes with tridentate NNO Schiff-base ligands

Mononuclear and trinuclear zinc(II) complexes (1 and 2) with tridentate NNO Schiff-base ligands (HL¹?=?N-2-pyridiylmethylidene-4-chloro-2-hydroxy-phenylamine, HL²?=?N-2-pyridiylmethylidene-2-hydroxy-5-chloro-phenylamine) have been synthesized and characterized by single-crystal X-ray diffraction and elemental analysis. The binding properties of zinc(II) complexes with calf thymus DNA (CT-DNA) and HSA were investigated by UV–visible, fluorescence, and circular dichroism spectra. The zinc(II) complexes bind significantly to CT-DNA by intercalation and bind to protein HSA through a static quenching mechanism. The in vitro cytotoxicity of the complexes on human tumor cells lines was assessed by 3-(4,5-dimathylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, Hoechst 33258 staining experiments.     

Synthesis,characterization, DNA binding studies and in vitro cytotoxicity of platinum(II)-dihalogenido complexes containing bidentate chelating N-donor ligands

Platinum(II) complexes, [Pt(L_x)X₂] (1–6), where X = Br or I and L_x = 2,2′-bipyridine or 1,10-phenanthroline derivatives (5,5′-dimethyl-2,2′-bipyridine (5-Mebpy), 4,4′-dimethyl-2,2′-bipyridine (4-Mebpy), and 5-amino-1,10-phenanthroline (5-NH₂phen)) were prepared. The complexes were characterized by the elemental analysis, mass spectrometry, infrared, and multinuclear (¹H, ¹³C and ¹⁹⁵Pt) 1-D and 2-D NMR spectroscopies, and by single-crystal X-ray analysis of [Pt(4-Mebpy)I₂] (4). All the platinum(II) complexes (1–6) were evaluated for in vitro cytotoxicity against human cancer cell lines A2780 and A2780R, and against non-malignant MRC5 cell line. All the complexes were nontoxic up to the 50 μM concentration, although they were found to readily bind to calf-thymus DNA (CT-DNA), as determined by spectrophotometric titration (K_b ≈ 10⁷ M^?1) and ethidium bromide displacement assay.     

Synthesis and spectral characterization of platinum(II) complexes containing eugenol,a natural allylphenol

For the first time, eugenol, a natural bioactive allylphenol, was introduced into coordination with platinum(II) by replacement of ethylene from Zeise’s salt with eugenol (Eug). The obtained complex, K[PtCl₃(Eug)] (1), was used as the key compound for preparation of the series of trans-[PtCl₂(Eug)(Amine)] (2–11), [PtCl(Eug)(8-O-quinoline)] (12) and [PtCl(Eug)(2-O₂C-quinoline)] (13). The synthesized complexes were characterized by elemental analyses, IR, ¹H NMR, ¹³C NMR, HSQS, HMBC, NOESY, and MS spectra. In 1–13 eugenol coordinates with Pt(II) at ethylenic double bond of the allyl group, the donor N of the amines is in trans-position in comparison with the double bond. A display of the trans-effect on the chemical shift of ¹H and ¹³C was remarked. Seven complexes were tested for cell in vitro cytotoxicity on human cancer cells. Complexes 3 and 12 exhibit high activities on Hep-G2 with IC₅₀ = 3.12 and 5.29 μM; 12 gives high activity against KB, Lu and MCF-7 with IC₅₀ = 0.43, 2.95 and 1.84 μM, respectively. Most of these IC₅₀ are lower than those of cisplatin.     

Synthesis and redistribution reactions of asymmetric σ-arylplatinum(II) complexes containing 4,7-phenanthroline

The mononuclear σ-aryl complexes of the type trans-[Pt(σ-C₆H₄R)(4,7-phen)(PPh₃)₂]OTf (R=4-CO₂Si^tBuPh₂, 4-CONHMe, 3-CO₂Si^tBuPh₂, 3-CONHMe; OTf=trifluoromethanesulfonate) containing a monodentate 4,7-phenanthroline (4,7-phen) ligand were prepared by an oxidative addition reaction of an aryl iodide with Pt(PPh₃)₄ to yield the key iodoplatinum(II) precursors trans-[PtI(σ-C₆H₄R)(PPh₃)₂], followed by halogen metathesis with one equivalent of 4,7-phen. The reaction of trans-[Pt(σ-C₆H₄R)(4,7-phen)(PPh₃)₂]OTf with labile complexes of the type trans-[Pt(OTf)L₂(σ-C₆H₄R′)] (L=PEt₃, R′=H; L=PPh₃, R′=4-CO₂Si^tBuPh₂, 3-CO₂Si^tBuPh₂, 3-CONHMe) afforded the asymmetric dinuclear complexes of the type trans-[Pt(σ-C₆H₄R)L₂(μ-4,7-phen)Pt(σ-C₆H₄R′)L′₂](OTf) ₂ (L=PPh₃, R=4-CO₂Si^tBuPh₂, L′=PEt₃, R′=H; L=L′=PPh₃, R=4-CONHMe, R′=4-CO₂Si^tBuPh₂; R=4-CO₂Si^tBuPh₂, R′=3-CONHMe; R=3-CONHMe, R′=3-CO₂Si^tBuPh₂) in which the 4,7-phen acts as a bridging bidentate ligand. The novel dinuclear species undergo an unusual redistribution reaction that is essentially thermoneutral at 298 K. The exchange process involves facile cleavage of a Pt-N bond and the rapid exchange of trans-[PtL₂(σ-aryl)] units in the equilibrium mixture.     

Platinum(II) complexes of 8-quinolylmethylphosphonates: Synthesis,characterization and antitumour activity

A series of novel platinum(II) complexes of diethyl (8-dqmp) and monoethyl (8-Hmqmp) ester of 8-quinolylmethylphosphonic acid has been prepared and studied. It was shown that molecular or ionic complexes could be isolated by reaction of these organophosphorus ligands with [PtX₄]²⁻ (X = Cl, Br), depending on the acidity of the reaction solution. In the neutral medium diester formed dihalide adducts, trans-[Pt(8-dqmp)₂X₂] (1 and 2), with N-bonded ligand through the quinoline nitrogen. Under acidic conditions (pH < 3) both ligands gave the quinolinium salt complexes [LH]₂[PtX₄] (3 and 4, L = 8-dqmp; 7 and 8, L = 8-Hmqmp), with protonated quinoline ligand as cation and tetrahalidoplatinate complex as anion. By heating in methanol complexes 3 and 4 were converted into the corresponding dimeric hexahalidodiplatinum complexes, [8-Hdqmp]₂[Pt₂X₆] (5 and 6). The chelate complex [Pt(8-mqmp)₂] (9), with monoester ligand bonded through the quinoline nitrogen and the deprotonated phosphonic acid oxygen and forming two seven-membered {N, O} chelate rings, was obtained in neutral and basic media by reaction of platinum(II) halides either with sodium or hydrochloride salt of this monoester. The complexes were identified and characterized by elemental and thermogravimetric analyses, conductometric measurements, and by spectroscopic studies. In vitro antitumour activity of complexes was evaluated against the human epidermoid KB and murine leukaemia L1210 cell lines. These results were compared with those obtained for the palladium(II) complexes of the same phosphonate ligands and with those of platinum(II) and palladium(II) complexes of diethyl and monoethyl 2-quinolylmethylphosphonate, in order to correlate the structural and biological properties of quinoline-based aminophosphonate compounds.     

Synthesis and characterization of Co(II), Ni(II), Zn(II) and Cu(II) complexes with a new tetraazamacrocyclic Schiff base ligand containing a piperazine moiety: X-ray crystal structure determination of the Co(II) complex

Two macrocyclic Schiff base ligands, L¹ [1+1] and L² [2+2], have been obtained in a one-pot cyclocondensation of 1,4-bis(2-formylphenyl)piperazine and 1,3-diaminopropane. Unfortunately, because of the low solubility of both ligands, their separation was unsuccessful. In the direct reaction of these mixed ligands (L¹ and L²) and the appropriate metal ions only [CoL¹(NO₃)]ClO₄, [NiL¹](ClO₄)₂, [CuL¹](ClO₄)₂ and [ZnL¹(NO₃)]ClO₄ complexes have been isolated. All the complexes were characterized by elemental analyses, IR, FAB-MS, conductivity measurements and in the case of the [ZnL¹(NO₃)]ClO₄ complex with NMR spectroscopy.     

Synthesis and comparative study of cytotoxicity and anticancer activity of Chalconoid-Co(II) metal complexes with 2-hydroxychalcones analogue containing naphthalene moiety

A series of six C1–C6 chalconoid based Co(II) complexes were prepared from bi-dentate 2-hydroxychalcones ligands L1-L6 containing naphthalene moiety. All synthesized metal-complexes have been evaluated to determine their cytotoxicity and anticancer activity against liver cancer cell line (Hep G2). Compared to standard 5-fluorouracil (IC₅₀ ?= ?98.61 ?μg/mL), the metal complex C6 exhibits more potency with IC₅₀ value 64.21 ?μg/mL against liver cancer cell line. While the remaining metal complexes such as C2, C4 and C5 are moderately active with IC₅₀ value 314.93, 414.05 and 376.00 ?μg/mL respectively. The complexes C1 and C3 with IC₅₀ value ?> ?1000 ?μg/mL are inadequate to display anticancer activity against Hep G2. Our perception towards the presence of organic group in the main structural moiety of complex C6 which associated with di-hydroxy (-OH) substituent at 3 and 4-position found more potent than complex C2, C4 and C5 which associated with halo (-Cl) substituent. The MTT assay revealed that the cytotoxicity and anticancer activity enhanced upon coordination of bio-ligand compared to free chalcone ligands. Therefore the present study may lead to the development of new class of anticancer drugs with structural modification.     

Synthesis and structure of Mn(II) and Zn(II) complexes containing 1,10-phenanthroline unit

The Mn(II) and Zn(II) complexes of N,N′-diisopropyl-1,10-phenanthroline-2,9-dimethanamine have been synthesised, and the structure of the two complexes have been studied by X-ray crystallography.     

Synthesis,structure and in vitro cytotoxicity of platinum(II) complexes containing eugenol and a quinolin‐8‐ol‐derived chelator

The synthesis of potassium (η²‐4‐allyl‐2‐methoxyphenol)trichloridoplatinate(II), K[PtCl₃(C₁₀H₁₂O₂)], ( 1 ), starting from Zeise's salt and Ocimum sanctum L. oil has been optimized. Starting from ( 1 ), three new platinum(II) complexes, namely (η²‐4‐allyl‐2‐methoxyphenol)chlorido(2‐methylquinolin‐8‐olato‐κ²N ,O )platinum(II), ( 2 ), (η²‐4‐allyl‐2‐methoxyphenol)chlorido(5‐nitroquinolin‐8‐olato‐κ²N ,O )platinum(II), ( 3 ), and (η²‐4‐allyl‐2‐methoxyphenol)chlorido(5,7‐dichloroquinolin‐8‐olato‐κ²N ,O )platinum(II), [Pt(C₉H₄Cl₂NO)Cl(C₁₀H₁₂O₂)], ( 4 ), containing eugenol and a quinolin‐8‐ol derivative (R‐OQ), have been synthesized and characterized by elemental analyses, MS, IR, ¹H NMR and NOESY spectra. For ( 1 ) and ( 4 ), single‐crystal X‐ray diffraction studies were also carried out. Complexes ( 2 )–( 4 ) show good inhibiting abilities on three human cancer cell lines, i.e. KB, Hep‐G2 and LU, with IC₅₀ values of 1.42–17.8 µM . Complex ( 3 ) gives an impressively high activity against KB, Hep‐G2, LU and MCF‐7, with IC₅₀ values of 1.42–4.91 µM , which are much lower than those of cisplatin and some other platinum(II) complexes.     

Synthesis,spectroscopy, X-ray crystal structure,and DFT studies on a platinum(II) Schiff-base complex

[PtCl₂(SMe₂)₂] reacts with (N,N′-bis(salicylidene)-1,2-cyclohexanediamine) to give (N,N′-bis(salicylidene)cyclohexane-1,2-diamine)platinum(II). The complex has been characterized by elemental analysis, infrared (IR), UV-Vis, and single-crystal X-ray diffraction. Pt(II) is in a square-planar environment, coordinated by a chelating N₂O₂ donor. Density functional theory (DFT) calculations such as geometry optimization, vibrational frequency, electronic properties, and natural bond orbital (NBO) have been performed for the platinum compound using the OLYP method at TZP(6-311G*) basis set. The optimization calculation shows that the geometry parameters can be reproduced with the OLYP/TZP basis set. Experimental IR frequencies and calculated vibrational frequencies support each other. Time-dependent DFT has been used for absorption wavelengths and results were compared with experimental data. Moreover, NBO analysis has been performed.     

Synthesis,DNA-binding,and photocleavage properties of Ru(II) complexes containing dppz-based ligand

A ligand ipdp (ipdp?=?indeno[1′,2′?:?5,6]pyrazino[2,3-i]dipyrido[3,2-a?:?2′,3′-c]phenazine-8-one) and its ruthenium complexes, [Ru(L)₂(ipdp)]²⁺ (L?=?bpy (2,2′-bipyridine), phen (1,10-phenanthroline)), have been synthesized and characterized by elemental analysis, electrospray mass spectra, and ¹H NMR. The interaction between the complexes and calf thymus DNA (CT-DNA) has been investigated by spectroscopic methods and viscosity measurements. The results indicate that the complexes can bind to CT-DNA in an intercalative mode. In addition, both complexes promote the photocleavage of plasmid pBR322 DNA under irradiation. The mechanistic studies reveal that singlet oxygen ¹O₂ plays a significant role in DNA photocleavage.     

1,3-Bis(2-alkyltetrazol-5-yl)triazenes and their Fe(II), Co(II) and Ni(II) complexes: Synthesis,spectroscopy, and thermal properties. Crystal structure of Fe(II) and Co(II) 1,3-bis(2-methyltetrazol-5-yl)triazenide complexes

Complexes ML¹₂ and ML²₂, with M = Fe^II, Co^II, Ni^II, and 1,3-bis(2-R-tetrazol-5-yl)triazenide ligands L¹ (R = Me) and L² (R = ^tBu), have been synthesized by the reaction of corresponding 1,3-bis(2-R-tetrazol-5-yl)triazenes with metal(II) salts in basic media and characterized by IR, UV–Vis spectroscopy, thermal and X-ray diffraction analyses. Both 1,3-bis(2-R-tetrazol-5-yl)triazenes were found to deprotonate on coordination and act as tridentate chelating ligands forming distorted MN₆ octahedra around metal(II) cations.     

Synthesis, characterization, structures and cytotoxic activity of palladium(II) and platinum(II) complexes containing bis(2-pyridylmethyl)amine and saccharinate

New palladium(II) and platinum(II) complexes containing bis(2-pyridylmethyl)amine (bpma) and saccharinate (sac), [Pd(bpma)(sac)](sac)·2H₂O (1), [Pt(bpma)(sac)](sac)·2H₂O (2), [Pd(bpma)Cl](sac)·2H₂O (3) and [Pt(bpma)(sac)]Cl·1.5H₂O (4), were synthesized and characterized by elemental analysis, IR, NMR and TG-DTA. A single-crystal X-ray analysis of 3 and 4 proved a distorted square-planar geometry around the metal ions with one tridentate bpma ligand and one Cl or sac monoanion. The [Pd(bpma)Cl]⁺ ions in 3 form dimers by intermolecular N-H?Cl and Pd?Pd interactions. The cations reside in the centers of a hydrogen-bonded honeycomb network formed by the uncoordinated sac ions and the lattice water molecules, while the cations of 4 are connected by N-H?Cl and OW-H?O hydrogen bonds into one-dimensional chains. Cyclic planar tetrameric and trimeric water clusters were observed in 3 and 4, respectively. Cytotoxicity of 1-4 was tested against A549, C6 and CHO cells. Although 2 and 4 have no cytotoxicity, the best results were achieved for 1 and 3. In particular, the cyctotoxic activity of 3 is comparable to cisplatin.     

Synthesis,characterization, DNA binding,DNA cleavage,antioxidant and in vitro cytotoxicity studies of ruthenium(II) complexes containing hydrazone ligands

The synthesis, spectral characterization, and biological studies of ruthenium(II) hydrazone complexes [RuCl(CO)(PPh₃)₂L] (where L = hydrazone ligands) have been carried out. The hydrazones are monobasic bidentate ligands with O and N as the donors and are preferably found in the enol form in all the complexes. The molecular structure of the ligands HL¹, HL²_, and HL³ were determined by single-crystal X-ray diffraction. The DNA binding studies of the ligands and complexes were carried out by absorption spectroscopic and viscosity measurements. The results revealed that the ligands and complexes bind to DNA via intercalation. The DNA cleavage activity of the complexes, evaluated by gel electrophoresis assay, revealed that the complexes are good DNA cleaving agents. The antioxidant properties of the complexes were evaluated against DPPH, OH, and NO radicals, which showed that the complexes have strong radical-scavenging. Further, the in vitro cytotoxic effect of the complexes examined on HeLa and MCF-7 cancer cell lines showed that the complexes exhibited significant anticancer activity.     

Synthesis and in vitro cytotoxicity of platinum(II) complexes with chiral N-monosubstituted 1,2-cyclohexyldiamine derivatives as the carrier groups

Eight platinum(II) complexes with the new chiral ligands, (1R,2R)-N ¹-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine (R) or (1S,2S)-N ¹-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine (S) as the carrier groups were designed, synthesized, and spectrally characterized. All platinum(II) complexes showed much better aqueous solubility than cisplatin and oxaliplatin. In vitro cytotoxicity of the compounds against human HepG-2, MCF-7, A549, and HCT-116 cell lines was evaluated. Results indicate that all compounds with R as the carrier group showed cytotoxicity against HCT-116, A549, and MCF-7 cell lines; however, all compounds with S as carrier group exhibited disappointing cytotoxicity against tested cell lines. Compound R2, bearing ClCH₂COO^- as leaving group, exhibited better cytotoxicity than that of carboplatin against A549 and MCF-7 cell lines and also showed close activity to oxaliplatin against HCT-116 cell line.